Medical cannabis for the treatment of chronic pain and other disorders: misconceptions and facts.

  title={Medical cannabis for the treatment of chronic pain and other disorders: misconceptions and facts.},
  author={Kevin P. Hill and Matthew D Palastro},
  journal={Polish archives of internal medicine},
  volume={127 11},
Recently, many countries have enacted new cannabis policies, including decriminalization of cannabis possession as well as legalization of medical and recreational cannabis. In this context, patients and their physicians have had an increasing number of conversations about the risks and benefits of cannabis. While cannabis and cannabinoids continue to be evaluated as pharmacotherapy for medical conditions, the best evidence currently exists for the following medical conditions: chronic pain… 

Cannabis Use in Hospitalized Patients with Chronic Pain

Cannabis use increased substantially from 2011 to 2015, while the rates of cannabis use in opioid users down-trended simultaneously, and Disparities in cannabis use among subgroups should be explored further.

Cannabis Use in Medical Oncology: A Brief Review

The pharmacology, the possible current indications for cannabis use in the oncology area, more specifically the treatment of nausea and vomiting induced by chemotherapy, and in appetite loss is explored, and the theoretical aspects in the literature of its antineoplastic effect are reviewed.

Cannabinoids: a new approach for pain control?

  • D. Lossignol
  • Medicine, Biology
    Current opinion in oncology
  • 2019
Analysis of available data related to the use of cannabinoids in medicine, with a special focus on pain management in cancer, finds Cannabidiol, a nontoxic phytocannabinoid with few side-effects is promising in various indications in medicine.

Social Factors and Animal Models of Cannabis Use.

  • L. Hood
  • Biology, Psychology
    International review of neurobiology
  • 2018

Occupational Allergies to Cannabis.

Low Dose Cannabidiol for the Treatment of Mild to Moderate Musculoskeletal Pain

The results of this study suggest that low dose CBD is an effective option for the treatment of mild to moderate musculoskeletal pain.

Prescription Opioid Distribution after the Legalization of Recreational Marijuana in Colorado

Analysis of the interval pre (2007–2012) versus post (2013–2017) marijuana legalization revealed statistically significant decreases for Colorado and Maryland, but not Utah, for pain medications, and additional study is needed to determine whether cannabis policy was associated with reductions in opioids used for chronic pain.

Medical cannabis treatment for chronic pain: Outcomes and prediction of response

This multicentre, questionnaire‐based prospective cohort was aimed to assess the long‐term effects of MC on chronic pain of various aetiologies and to identify predictors for MC treatment success.

Childhood Religious Affiliation Type Is Associated with Alcohol, but Not Cannabis Use in Adults.

Overall, childhood religious affiliation type was not associated with cannabis use milestones as had been previously reported for alcohol use milestones, which suggests important differences between alcohol and cannabis use characteristics that may have implications for future substance use research, prevention, and treatment.




Cannabis and Pain: A Clinical Review

With increased use of medical cannabis as pharmacotherapy for pain comes a need for comprehensive risk-benefit discussions that take into account cannabis' significant possible side effects.

Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.

  • K. Hill
  • Medicine, Psychology
  • 2015
Use of marijuana for chronic pain, neuropathic pain, and spasticity due to multiple sclerosis is supported by high-quality evidence, and Physicians should educate patients about medical marijuana to ensure that it is used appropriately and that patients will benefit from its use.

Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed

Evidence of cannabis’ effects on two psychiatric conditions: post-traumatic stress disorder and psychotic disorders is discussed to discuss two viewpoints regarding the benefit and harm of cannabis use for these conditions.

Self-reported cannabis use characteristics, patterns and helpfulness among medical cannabis users

It is indicated that medical cannabis users use and perceive cannabis to be beneficial for multiple conditions, some for which cannabis is not specifically prescribed or allowed at the state level; and report similar rates of disordered use as compared with population estimates among regular users.

Cannabis (Medical Marijuana) Treatment for Motor and Non–Motor Symptoms of Parkinson Disease: An Open-Label Observational Study

The study suggests that cannabis might have a place in the therapeutic armamentarium of PD, with significant improvement of sleep and pain scores and no significant adverse effects of the drug were observed.

Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.

There was moderate- quality evidence to support the use of cannabinoids for the treatment of chronic pain and spasticity and low-quality evidence suggesting that cannabinoids were associated with improvements in nausea and vomiting due to chemotherapy, weight gain in HIV infection, sleep disorders, and Tourette syndrome.

The Use of Medicinal Marijuana for Posttraumatic Stress Disorder: A Review of the Current Literature.

While the literature to date is suggestive of a potential decrease in PTSD symptomatology with the use of medicinal marijuana, there is a notable lack of large-scale trials, making any final conclusions difficult to confirm at this time.

Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial

Smoked cannabis was generally well tolerated and effective when added to concomitant analgesic therapy in patients with medically refractory pain due to HIV DSPN.

PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program

Cannabis is associated with reductions in PTSD symptoms in some patients, and prospective, placebo-controlled study is needed to determine efficacy of cannabis and its constituents in treating PTSD.

Cannabidiol for the treatment of psychosis in Parkinson’s disease

Preliminary data suggest that CBD may be effective, safe and well tolerated for the treatment of the psychosis in PD.